The United Kingdom's market has recently experienced downturns, with the FTSE 100 and FTSE 250 indices closing lower amid concerns over weak trade data from China, which has impacted companies closely tied to its economic fortunes. In this challenging environment, identifying high-growth tech stocks in the UK requires a focus on companies with strong innovation capabilities and resilience to global economic fluctuations. Top 10 High Growth Tech Companies In The United Kingdom Name Revenue Growth Earnings Growth Growth Rating Audioboom Group 8.84% 59.33% ★★★★★☆ ENGAGE XR Holdings 22.08% 84.46% ★★★★★★ YouGov 3.98% 64.42% ★★★★★☆ Pinewood Technologies Group 24.99% 40.16% ★★★★★☆ Oxford Biomedica 16.89% 80.47% ★★★★★☆ Windar Photonics 37.85% 47.21% ★★★★★☆ Huddled Group 21.70% 114.65% ★★★★★☆ Trustpilot Group 15.20% 40.20% ★★★★★☆ Quantum Base Holdings 132.55% 92.87% ★★★★★☆ Faron Pharmaceuticals Oy 55.41% 54.99% ★★★★★☆ Click here to see the full list of 41 stocks from our UK High Growth Tech and AI Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Aptitude Software Group Simply Wall St Growth Rating: ★★★★☆☆ Overview: Aptitude Software Group plc, with a market cap of £185.73 million, offers financial management software solutions across the United Kingdom and international markets. Operations: Aptitude Software Group generates revenue primarily through its financial management software segment, which reported £70.04 million in revenue. Aptitude Software Group has demonstrated robust growth with earnings rising by 20.7% over the past year, surpassing the software industry's growth of 17.1%. This performance is underpinned by a strategic focus on innovative products like Fynapse, which recently secured a significant contract due to its advanced AI and data management capabilities, enhancing the company's recurring revenue streams. Additionally, Aptitude’s commitment to shareholder returns is evident from its recent share repurchase of £4 million and consistent dividend payments, reflecting confidence in its financial health and future prospects. Get an in-depth perspective on Aptitude Software Group's performance by reading our health report here. Learn about Aptitude Software Group's historical performance.LSE:APTD Revenue and Expenses Breakdown as at Jun 2025 Genus Simply Wall St Growth Rating: ★★★★☆☆ Overview: Genus plc is an animal genetics company with operations spanning North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia and has a market capitalization of approximately £1.26 billion. Operations: Genus generates revenue primarily through its two main segments: Genus ABS, which contributes approximately £311.10 million, and Genus PIC, contributing around £358 million. The company operates within the animal genetics industry across various global regions. Story Continues Genus's recent FDA approval marks a pivotal advancement, positioning it to capitalize on the U.S. food supply chain with its PRP gene edit technology—a significant stride given the global impact of PRRS on pig populations. This regulatory milestone complements Genus's robust R&D focus, where expenses have strategically fueled innovations critical to tackling industry-wide challenges like antibiotic resistance. Financially, Genus is navigating a path to profitability with expected earnings growth of 46.67% annually and revenue growth forecasts aligning slightly above the UK market average at 4% per year compared to 3.7%. This trajectory is supported by a positive free cash flow and an anticipated shift into profitability within three years, showcasing potential amidst a challenging biotech landscape. Click to explore a detailed breakdown of our findings in Genus' health report. Gain insights into Genus' past trends and performance with our Past report.LSE:GNS Revenue and Expenses Breakdown as at Jun 2025 Kainos Group Simply Wall St Growth Rating: ★★★★☆☆ Overview: Kainos Group plc provides digital technology services across the United Kingdom, Ireland, North America, Central Europe, and internationally with a market cap of £912.94 million. Operations: Kainos Group plc generates revenue primarily through its Digital Services (£197.17 million), Workday Products (£71.35 million), and Workday Services (£98.72 million) segments. Kainos Group plc, a UK-based software company, demonstrates robust financial health with an expected annual revenue growth of 7.1%, outpacing the UK market average of 3.7%. This growth is complemented by an impressive forecast of earnings increasing at 16.9% annually. Recently, Kainos completed a significant share repurchase program, buying back shares worth £30 million, underscoring its commitment to shareholder value amidst challenging market conditions. The firm's strategic focus on enhancing its software solutions portfolio through consistent R&D investment positions it well within the competitive tech landscape despite a recent dip in net income to £35.56 million from last year's £48.72 million. Unlock comprehensive insights into our analysis of Kainos Group stock in this health report. Assess Kainos Group's past performance with our detailed historical performance reports.LSE:KNOS Revenue and Expenses Breakdown as at Jun 2025 Make It Happen Take a closer look at our UK High Growth Tech and AI Stocks list of 41 companies by clicking here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:APTD LSE:GNS and LSE:KNOS. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Exploring High Growth Tech Stocks in the UK for June 2025
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...